Track topics on Twitter Track topics that are important to you
Drug discovery firm Bridge Medicines has appointed William Polvino CEO. Polvino most recently served as president and CEO of Denmark-based Veloxis Pharmaceuticals (NASDAQ: VELO), and ran Helsinn Therapeutics before that. Bridge, based in New York, launched last October to extend the work of the non-profit Tri-Institutional Therapeutics Discovery Institute. With Polvino’s appointment, Bridge says interim […]
Original Article: William Polvino Named CEO of Bridge MedicinesNEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...